U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory B-Cell Prolymphocytic Leukemia

MedGen UID:
1676333
Concept ID:
C4763801
Neoplastic Process

Definition

B-cell prolymphocytic leukemia that is resistant to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory B-Cell Prolymphocytic Leukemia

Professional guidelines

PubMed

Boyd K, Dearden CE
Expert Rev Anticancer Ther 2008 Apr;8(4):525-33. doi: 10.1586/14737140.8.4.525. PMID: 18402519
Dumont FJ
Expert Rev Anticancer Ther 2002 Feb;2(1):23-35. doi: 10.1586/14737140.2.1.23. PMID: 12113063
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Recent clinical studies

Etiology

Chen LY, Eyre TA
Eur J Haematol 2022 Nov;109(5):590-592. Epub 2022 Aug 5 doi: 10.1111/ejh.13837. PMID: 35871485
Gribben JG, Hallek M
Br J Haematol 2009 Mar;144(6):818-31. Epub 2009 Jan 8 doi: 10.1111/j.1365-2141.2008.07557.x. PMID: 19183194
Nguyen DD, Cao TM, Dugan K, Starcher SA, Fechter RL, Coutre SE
Clin Lymphoma 2002 Sep;3(2):105-10. doi: 10.3816/clm.2002.n.016. PMID: 12435283
Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, Siakantaris MP
Med Oncol 2001;18(2):99-107. doi: 10.1385/mo:18:2:99. PMID: 11778765
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Diagnosis

Bell S, Lattanzio N, Braham J, Campdesuner V, Abdelal Q, Vartanov A, Pelayo M
J Investig Med High Impact Case Rep 2021 Jan-Dec;9:2324709621990767. doi: 10.1177/2324709621990767. PMID: 33533282Free PMC Article
Boidol B, Kornauth C, van der Kouwe E, Prutsch N, Kazianka L, Gültekin S, Hoermann G, Mayerhoefer ME, Hopfinger G, Hauswirth A, Panny M, Aretin MB, Hilgarth B, Sperr WR, Valent P, Simonitsch-Klupp I, Moriggl R, Merkel O, Kenner L, Jäger U, Kubicek S, Staber PB
Blood 2017 Dec 7;130(23):2499-2503. Epub 2017 Sep 27 doi: 10.1182/blood-2017-05-785683. PMID: 28972014
Johnson SA
Hematol J 2004;5 Suppl 1:S50-61. doi: 10.1038/sj.thj.6200391. PMID: 15079153
McCune SL, Gockerman JP, Moore JO, Decastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA
Leuk Lymphoma 2002 May;43(5):1007-11. doi: 10.1080/10428190290021597. PMID: 12148879
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Therapy

Boyd K, Dearden CE
Expert Rev Anticancer Ther 2008 Apr;8(4):525-33. doi: 10.1586/14737140.8.4.525. PMID: 18402519
Frampton JE, Wagstaff AJ
Drugs 2003;63(12):1229-43; discussion 1245-6. doi: 10.2165/00003495-200363120-00003. PMID: 12790693
McCune SL, Gockerman JP, Moore JO, Decastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA
Leuk Lymphoma 2002 May;43(5):1007-11. doi: 10.1080/10428190290021597. PMID: 12148879
Pangalis GA, Dimopoulou MN, Angelopoulou MK, Tsekouras C, Vassilakopoulos TP, Vaiopoulos G, Siakantaris MP
Med Oncol 2001;18(2):99-107. doi: 10.1385/mo:18:2:99. PMID: 11778765
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Prognosis

Liu J, Tan X, Ma YY, Liu Y, Gao L, Gao L, Kong P, Peng XG, Zhang X, Zhang C
Clin Lymphoma Myeloma Leuk 2019 Jul;19(7):e349-e358. Epub 2019 Mar 25 doi: 10.1016/j.clml.2019.03.012. PMID: 31076372
Frampton JE, Wagstaff AJ
Drugs 2003;63(12):1229-43; discussion 1245-6. doi: 10.2165/00003495-200363120-00003. PMID: 12790693
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261
Saven A, Lee T, Schlutz M, Jacobs A, Ellison D, Longmire R, Piro L
J Clin Oncol 1997 Jan;15(1):37-43. doi: 10.1200/JCO.1997.15.1.37. PMID: 8996122
Berliner N
Hematol Oncol Clin North Am 1990 Apr;4(2):473-87. PMID: 2182603

Clinical prediction guides

Fiegl M, Stauder R, Steurer M, Mian M, Hopfinger G, Brychtova Y, Skrabs C, Zabernigg A, Schmid F, Haslbaur F, Winder G, Walder A, Lang A, Voskova D, Greil R, Mayer J, Gastl G; Austrian Collaborative Study Group on Alemtuzumab in Chronic Lymphocytic Leukemia, in cooperation with The Czech Leukemia Study Group for Life, CELL
Ann Hematol 2014 Feb;93(2):267-77. Epub 2013 Nov 30 doi: 10.1007/s00277-013-1966-z. PMID: 24292560
Gandhi V, Tam C, O'Brien S, Jewell RC, Rodriguez CO Jr, Lerner S, Plunkett W, Keating MJ
J Clin Oncol 2008 Mar 1;26(7):1098-105. doi: 10.1200/JCO.2007.14.1986. PMID: 18309944
Frampton JE, Wagstaff AJ
Drugs 2003;63(12):1229-43; discussion 1245-6. doi: 10.2165/00003495-200363120-00003. PMID: 12790693
Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R
Semin Oncol 2000 Apr;27(2 Suppl 5):52-7. PMID: 10877053
Kalil N, Cheson BD
Drugs Aging 2000 Jan;16(1):9-27. doi: 10.2165/00002512-200016010-00002. PMID: 10733261

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...